Skip to main content
European Heart Journal. Cardiovascular Pharmacotherapy logoLink to European Heart Journal. Cardiovascular Pharmacotherapy
. 2023 Jan 31;9(3):293. doi: 10.1093/ehjcvp/pvad011

Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis

PMCID: PMC10084092  PMID: 36722017

This is a corrigendum to: Giulia Ferrannini, Lars H Lund, Lina Benson, Manfredi Rizzo, Wael Almahmeed, Giuseppe M C Rosano, Gianluigi Savarese, Francesco Cosentino, Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis, European Heart Journal—Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 10–17, https://doi.org/10.1093/ehjcvp/pvac044

In the originally published version of this manuscript the following statement was inadvertently omitted from the ‘Funding’ section:

‘This study was supported by the Italian Ministry of Health (Ricerca Corrente) 20/1819.’

This error has been corrected.


Articles from European Heart Journal — Cardiovascular Pharmacotherapy are provided here courtesy of Oxford University Press

RESOURCES